2017 Q4 Form 10-Q Financial Statement

#000156459017024660 Filed on December 07, 2017

View on sec.gov

Income Statement

Concept 2017 Q4 2016 Q4
Revenue $79.07M $75.97M
YoY Change 4.07% -6.04%
Cost Of Revenue $42.40M $38.02M
YoY Change 11.53% -6.95%
Gross Profit $36.67M $37.96M
YoY Change -3.4% -5.12%
Gross Profit Margin 46.37% 49.96%
Selling, General & Admin $31.36M $31.90M
YoY Change -1.68% 15.3%
% of Gross Profit 85.52% 84.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.510M $2.210M
YoY Change 13.57% 3.27%
% of Gross Profit 6.85% 5.82%
Operating Expenses $31.36M $31.90M
YoY Change -1.68% 15.3%
Operating Profit $5.309M $6.063M
YoY Change -12.44% -50.88%
Interest Expense -$1.700M $1.023M
YoY Change -266.18% -28.36%
% of Operating Profit -32.02% 16.87%
Other Income/Expense, Net -$100.0K -$200.0K
YoY Change -50.0% -77.78%
Pretax Income $3.503M $4.849M
YoY Change -27.76% -51.59%
Income Tax -$6.000K $1.469M
% Of Pretax Income -0.17% 30.29%
Net Earnings $3.509M $3.380M
YoY Change 3.82% -42.64%
Net Earnings / Revenue 4.44% 4.45%
Basic Earnings Per Share $0.41 $0.69
Diluted Earnings Per Share $0.41 $0.68
COMMON SHARES
Basic Shares Outstanding 8.611M 49.29M
Diluted Shares Outstanding 8.611M 49.48M

Balance Sheet

Concept 2017 Q4 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.700M $20.70M
YoY Change -72.46% 20600.0%
Cash & Equivalents $5.796M $20.71M
Short-Term Investments
Other Short-Term Assets $4.000M $8.700M
YoY Change -54.02% -15.53%
Inventory $51.40M $34.42M
Prepaid Expenses
Receivables $31.30M $16.61M
Other Receivables $0.00 $0.00
Total Short-Term Assets $92.40M $80.47M
YoY Change 14.82% 10.09%
LONG-TERM ASSETS
Property, Plant & Equipment $38.80M $46.10M
YoY Change -15.83% 26.99%
Goodwill $63.75M
YoY Change
Intangibles $108.6M
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.800M $97.40M
YoY Change -97.13% 4.62%
Total Long-Term Assets $160.3M $315.9M
YoY Change -49.25% 4.45%
TOTAL ASSETS
Total Short-Term Assets $92.40M $80.47M
Total Long-Term Assets $160.3M $315.9M
Total Assets $252.7M $396.3M
YoY Change -36.24% 5.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.70M $23.79M
YoY Change -34.01% -21.23%
Accrued Expenses $16.60M $16.00M
YoY Change 3.75% -49.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $9.000M
YoY Change
Total Short-Term Liabilities $41.30M $39.75M
YoY Change 3.89% -35.46%
LONG-TERM LIABILITIES
Long-Term Debt $57.60M $50.74M
YoY Change 13.53% -32.53%
Other Long-Term Liabilities $153.8M $140.8M
YoY Change 9.2% -13.33%
Total Long-Term Liabilities $211.4M $191.6M
YoY Change 10.35% -19.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $41.30M $39.75M
Total Long-Term Liabilities $211.4M $191.6M
Total Liabilities $252.7M $231.3M
YoY Change 9.24% -22.71%
SHAREHOLDERS EQUITY
Retained Earnings -$935.0M
YoY Change
Common Stock $1.083B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $100.0K $148.2M
YoY Change
Total Liabilities & Shareholders Equity $252.7M $396.3M
YoY Change -36.24% 5.55%

Cashflow Statement

Concept 2017 Q4 2016 Q4
OPERATING ACTIVITIES
Net Income $3.509M $3.380M
YoY Change 3.82% -42.64%
Depreciation, Depletion And Amortization $2.510M $2.210M
YoY Change 13.57% 3.27%
Cash From Operating Activities -$20.85M $2.450M
YoY Change -951.02% -75.62%
INVESTING ACTIVITIES
Capital Expenditures -$300.0K -$3.360M
YoY Change -91.07% 9.45%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$300.0K -$3.360M
YoY Change -91.07% 9.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 23.08M 270.0K
YoY Change 8448.15% -103.88%
NET CHANGE
Cash From Operating Activities -20.85M 2.450M
Cash From Investing Activities -300.0K -3.360M
Cash From Financing Activities 23.08M 270.0K
Net Change In Cash 1.930M -640.0K
YoY Change -401.56% -3300.0%
FREE CASH FLOW
Cash From Operating Activities -$20.85M $2.450M
Capital Expenditures -$300.0K -$3.360M
Free Cash Flow -$20.55M $5.810M
YoY Change -453.7% -55.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9000000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
3380000
us-gaap Net Income Loss
NetIncomeLoss
-511000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1341000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15915000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-511000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7398000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6203000
us-gaap Inventory Write Down
InventoryWriteDown
165000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-974000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
596000
vnce Deferred Income Tax Benefit Expense
DeferredIncomeTaxBenefitExpense
-4710000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-456000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
7213000
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
us-gaap Inventory Write Down
InventoryWriteDown
815000
us-gaap Share Based Compensation
ShareBasedCompensation
1383000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-32706000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-185000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-34152000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
12677000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-12677000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
118567000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
125767000
us-gaap Repayments Of Debt
RepaymentsOfDebt
9000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
29047000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
63773000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
40000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4731000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
555000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
46408000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
61304000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15255000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14475000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6230000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20705000
vnce Cash Payment On Tax Receivable Agreements Obligation
CashPaymentOnTaxReceivableAgreementsObligation
22262000
us-gaap Interest Paid
InterestPaid
3104000
us-gaap Interest Paid
InterestPaid
2107000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
78000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
319000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
89000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1447000
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5372000
CY2017Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.10
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
Pursuant to the Reverse Stock Split, every 10 shares of the Company’s issued and outstanding common stock were automatically converted into one share of common stock. No fractional shares were issued if, as a result of the Reverse Stock Split, a stockholder would otherwise have been entitled to a fractional share. Instead, each stockholder was entitled to receive a cash payment based on a pre-split cash in lieu rate of $0.48, which was the average closing price per share on the New York Stock Exchange for the five consecutive trading days immediately preceding October 23, 2017.
CY2017Q4 vnce Number Of Fractional Shares
NumberOfFractionalShares
0
CY2017Q4 vnce Stock Conversion Cash In Lieu Of Share Per Share
StockConversionCashInLieuOfSharePerShare
0.48
CY2017Q4 vnce Trading Days Used For Calculating Stock Conversion Cash In Lieu Of Share Per Share
TradingDaysUsedForCalculatingStockConversionCashInLieuOfSharePerShare
P5D
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
69253000
CY2017Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
69253000
CY2017Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
113820000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5821000
CY2017Q4 vnce Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Impairment Loss
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairmentLoss
30750000
CY2017Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
113820000
CY2017Q1 vnce Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Impairment Loss
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairmentLoss
30750000
CY2017Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
149000
CY2016Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
150000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
449000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
449000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
598000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
598000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
598000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
598000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
598000
CY2017Q4 vnce Non Financial Assets Fair Value Disclosure
NonFinancialAssetsFairValueDisclosure
0
CY2017Q1 vnce Non Financial Assets Fair Value Disclosure
NonFinancialAssetsFairValueDisclosure
0
CY2017Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
0
CY2017Q1 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
0
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
68076000
CY2017Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
50200000
CY2017Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1455000
CY2017Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1902000
CY2015Q2 vnce Loan Cap On Revolving Credit Facility
LoanCapOnRevolvingCreditFacility
70000000
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
53598000
CY2017Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
40771000
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2220000
CY2017Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2242000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
225812
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
17150
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
70323
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
172639
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
71575
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
45.27
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.36
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
42.76
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.83
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
44.77
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M19D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
101064
CY2017Q4 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1
84000
CY2017Q4 us-gaap Share Based Compensation
ShareBasedCompensation
429000
CY2016Q4 us-gaap Share Based Compensation
ShareBasedCompensation
638000
CY2017Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
439
CY2016Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
19246
CY2017Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
183566
CY2016Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
76443
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
189060
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
72362
us-gaap Loss Contingency Date Of Dismissal
LossContingencyDateOfDismissal
2017-10-06
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2

Files In Submission

Name View Source Status
0001564590-17-024660-index-headers.html Edgar Link pending
0001564590-17-024660-index.html Edgar Link pending
0001564590-17-024660.txt Edgar Link pending
0001564590-17-024660-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vnce-10q_20171028.htm Edgar Link pending
vnce-20171028.xml Edgar Link completed
vnce-20171028.xsd Edgar Link pending
vnce-20171028_cal.xml Edgar Link unprocessable
vnce-20171028_def.xml Edgar Link unprocessable
vnce-20171028_lab.xml Edgar Link unprocessable
vnce-20171028_pre.xml Edgar Link unprocessable
vnce-ex101_46.htm Edgar Link pending
vnce-ex311_8.htm Edgar Link pending
vnce-ex312_7.htm Edgar Link pending
vnce-ex321_6.htm Edgar Link pending
vnce-ex322_9.htm Edgar Link pending